Deutsche Bank AG Sells 155,838 Shares of Aspen Aerogels, Inc. $ASPN

Key Points

• Deutsche Bank AG has reduced its stake in Aspen Aerogels by 37.5%, now holding approximately 0.32% of the company, valued at $1.66 million.
• Aspen Aerogels posted a quarterly revenue of $78.02 million, exceeding expectations, but reported a negative net margin of 78.53% and an EPS of ($0.04), beating estimates.
• Analysts have mixed ratings for Aspen Aerogels, with a consensus price target of $19.50, reflecting a range from "Strong Buy" to "Sell" ratings.

Deutsche Bank AG reduced its holdings in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 37.5% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 259,553 shares of the construction company's stock after selling 155,838 shares during the quarter. Deutsche Bank AG owned about 0.32% of Aspen Aerogels worth $1,659,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. GAMMA Investing LLC grew its position in shares of Aspen Aerogels by 1,998.7% in the first quarter. GAMMA Investing LLC now owns 3,316 shares of the construction company's stock valued at $210,000 after purchasing an additional 3,158 shares during the last quarter. Banque Cantonale Vaudoise acquired a new stake in shares of Aspen Aerogels in the first quarter valued at about $45,000. Exchange Traded Concepts LLC grew its position in shares of Aspen Aerogels by 460.4% in the first quarter. Exchange Traded Concepts LLC now owns 7,436 shares of the construction company's stock valued at $48,000 after purchasing an additional 6,109 shares during the last quarter. Sandia Investment Management LP acquired a new stake in shares of Aspen Aerogels in the fourth quarter valued at about $89,000. Finally, CWM LLC grew its position in shares of Aspen Aerogels by 2,137.9% in the first quarter. CWM LLC now owns 8,325 shares of the construction company's stock valued at $53,000 after purchasing an additional 7,953 shares during the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Price Performance

NYSE ASPN traded down $0.07 during trading on Thursday, reaching $6.96. 1,337,410 shares of the company traded hands, compared to its average volume of 2,533,787. The company has a debt-to-equity ratio of 0.34, a quick ratio of 3.31 and a current ratio of 3.98. The stock's 50 day moving average price is $6.99 and its two-hundred day moving average price is $6.66. The company has a market cap of $572.81 million, a price-to-earnings ratio of -1.83 and a beta of 2.73. Aspen Aerogels, Inc. has a 1-year low of $4.16 and a 1-year high of $30.24.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) earnings per share for the quarter, beating analysts' consensus estimates of ($0.12) by $0.08. The company had revenue of $78.02 million for the quarter, compared to the consensus estimate of $72.53 million. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%.The company's quarterly revenue was down 33.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.21 earnings per share. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. As a group, analysts anticipate that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the company. Canaccord Genuity Group decreased their target price on Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating on the stock in a research report on Friday, August 8th. Barclays downgraded Aspen Aerogels from an "equal weight" rating to an "underweight" rating and lifted their target price for the stock from $7.00 to $16.00 in a research report on Monday, August 11th. Finally, Oppenheimer downgraded Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research report on Thursday, May 8th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Aspen Aerogels has a consensus rating of "Moderate Buy" and a consensus target price of $19.50.

Insiders Place Their Bets

In other Aspen Aerogels news, CAO Santhosh P. Daniel sold 4,410 shares of Aspen Aerogels stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total transaction of $32,237.10. Following the sale, the chief accounting officer directly owned 19,879 shares of the company's stock, valued at approximately $145,315.49. The trade was a 18.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 4.30% of the company's stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.